Series D funding round for Impel Pharmaceuticals raising $68M in December 2018
Series D funding round for Impel Pharmaceuticals raising $68M in December 2018
| Investor | Firm Type | Partner |
|---|
KKR & Co. Inc.LEAD | Private | — |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — |
This company has completed 4 funding rounds. Current round is highlighted.
Total Raised
$166M
Top Valuation
-
Impel Pharmaceuticals raised $68M in a Series D round.
The round was announced on 12/01/18.
The round was led by Ali Satvat, Robert Mittendorff.